Health Care [ 12/12 ] | Biotechnology [ 62/74 ]
NASDAQ | Common Stock
CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases.
It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; and CB5138 Analogs, which is in preclinical study to treat idiopathic pulmonary fibrosis and other fibrotic diseases.
CohBar, Inc. was incorporated in 2007 and is based in Menlo Park, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 14, 23 | -1.49 Decreased by -65.60% | - |
| May 15, 23 | -0.75 Increased by +37.91% | -0.60 Decreased by -24.18% |
| Mar 9, 23 | -1.30 Decreased by -8.33% | -0.90 Decreased by -44.44% |
| Nov 8, 22 | -0.82 Increased by +45.33% | -1.02 Increased by +19.61% |
| Aug 15, 22 | -0.90 Increased by +62.50% | -1.20 Increased by +25.00% |
| May 16, 22 | -1.20 Increased by +42.86% | -1.35 Increased by +11.11% |
| Mar 29, 22 | -1.20 Increased by +50.00% | -1.65 Increased by +27.27% |
| Nov 15, 21 | -1.50 Increased by +16.67% | -2.20 Increased by +31.82% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 23 | 0.00 Decreased by N/A% | -4.33 M Decreased by -60.09% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 23 | 0.00 Decreased by N/A% | -2.03 M Increased by +37.71% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 22 | 0.00 Decreased by N/A% | -3.67 M Decreased by -31.45% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 22 | 0.00 Decreased by N/A% | -2.39 M Increased by +30.10% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 22 | 0.00 Decreased by N/A% | -2.71 M Increased by +48.19% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 22 | 0.00 Decreased by N/A% | -3.26 M Increased by +19.23% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 21 | 0.00 Decreased by N/A% | -2.79 M Increased by +40.69% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 21 | 0.00 Decreased by N/A% | -3.42 M Decreased by -5.71% | Decreased by N/A% Decreased by N/A% |